Apart from mutations affecting components of the telomerase complex, surfactant metabolism and TGF-β signaling, CPFE has been associated with a mutation in the gene encoding the receptor for advanced glycation end-products (RAGE), previously associated with other lung diseases, including COPD and IPF [143]. The gene discussed is AGER; the disease is chronic obstructive pulmonary disease.